Rhumbline Advisers Immutep LTD Transaction History
Rhumbline Advisers
- $121 Billion
- Q3 2025
A detailed history of Rhumbline Advisers transactions in Immutep LTD stock. As of the latest transaction made, Rhumbline Advisers holds 21,832 shares of IMMP stock, worth $40,607. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,832
Previous 26,717
18.28%
Holding current value
$40,607
Previous $43,000
9.3%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding IMMP
# of Institutions
37Shares Held
2.36MCall Options Held
1.42KPut Options Held
20K-
Black Rock Inc. New York, NY839KShares$1.56 Million0.0% of portfolio
-
Meridian Wealth Management, LLC421KShares$782,8740.03% of portfolio
-
Sender CO & Partners, Inc. New York, NY216KShares$401,5010.13% of portfolio
-
Morgan Stanley New York, NY166KShares$308,6960.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA95.3KShares$177,1720.0% of portfolio
About IMMUTEP Ltd
- Ticker IMMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,000
- Market Cap $161M
- Description
- Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...